These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
64. [Effect of the preparations Adreson and Decadron given to expectant mothers on the postnatal state of newborn infants]. Samochowiec E; Osuch-Jaczewska R; Sieroń G; Kalacińska M; Mikulska M; Poreba A; Ulfik A Ginekol Pol; 1979 Aug; 50(8):685-8. PubMed ID: 90637 [No Abstract] [Full Text] [Related]
65. Glucocorticoids and the Lung. Gerber AN Adv Exp Med Biol; 2015; 872():279-98. PubMed ID: 26215999 [TBL] [Abstract][Full Text] [Related]
66. Letter: Oestrogens and the respiratory-distress syndrome. Notelovitz M Lancet; 1974 Mar; 1(7856):505-6. PubMed ID: 4131903 [No Abstract] [Full Text] [Related]
67. Postnatal prevention and treatment of surfactant deficiency. Robertson B Eur J Obstet Gynecol Reprod Biol; 1989 Jul; 32(1):11-12. PubMed ID: 2767315 [No Abstract] [Full Text] [Related]
68. Glucocorticoid effects in the fetal lung. Ballard PL; Benson BJ; Brehier A Am Rev Respir Dis; 1977 Jun; 115(6 Pt 2):29-36. PubMed ID: 577381 [No Abstract] [Full Text] [Related]
69. Glucocorticoid prophylaxis for respiratory distress syndrome: a review of potential toxicity. Taeusch HW J Pediatr; 1975 Oct; 87(4):617-23. PubMed ID: 1099187 [TBL] [Abstract][Full Text] [Related]
70. Incidence of idiopathic respiratory distress syndrome during the last ten years. Amiel-Tison C; Barbiani M; Hornych H; Tchobroutsky C; Henrion R Eur J Obstet Gynecol Reprod Biol; 1981 Feb; 11(4):263-72. PubMed ID: 7194817 [TBL] [Abstract][Full Text] [Related]
71. Born before their time into this breathing world. Br Med J; 1976 Dec; 2(6049):1403-4. PubMed ID: 1036968 [No Abstract] [Full Text] [Related]
72. The impact of maternal asthma on the fetal lung: Outcomes, mechanisms and interventions. Robinson JL; Gatford KL; Clifton VL; Morrison JL; Stark MJ Paediatr Respir Rev; 2024 Sep; 51():38-45. PubMed ID: 38195368 [TBL] [Abstract][Full Text] [Related]
73. Prenatal treatment with thyrotrophin releasing hormone to prevent neonatal respiratory distress. de Zegher F; Spitz B; Devlieger H Arch Dis Child; 1992 Apr; 67(4 Spec No):450-4. PubMed ID: 1316739 [No Abstract] [Full Text] [Related]
74. Unitary concept for prevention and treatment of respiratory-distress syndrome. Ghadimi H; Arulanantham K; Desai L Lancet; 1973 Jul; 2(7821):126-8. PubMed ID: 4124046 [No Abstract] [Full Text] [Related]
75. What is the identity of fibroblast-pneumocyte factor? King G; Smith ME; Cake MH; Nielsen HC Pediatr Res; 2016 Dec; 80(6):768-776. PubMed ID: 27500537 [TBL] [Abstract][Full Text] [Related]
76. Fibroblast-pneumonocyte factor. Smith BT; Post M Am J Physiol; 1989 Oct; 257(4 Pt 1):L174-8. PubMed ID: 2679137 [TBL] [Abstract][Full Text] [Related]
77. Lung fluid during postnatal transition. Andersson S; Pitkänen O; Janér C; Helve O Chin Med J (Engl); 2010 Oct; 123(20):2919-23. PubMed ID: 21034607 [No Abstract] [Full Text] [Related]
78. A controlled trial of antepartum glucocorticoid treatment for prevention of the respiratory distress syndrome in premature infants, by G. C. Liggins, MB, PhD, FRCOG, and R. N. Howie, MB, MRACP, Pediatrics, 1972;50:515-525. Avery CM Pediatrics; 1998 Jul; 102(1 Pt 2):250-1. PubMed ID: 9651447 [No Abstract] [Full Text] [Related]
79. The credibility of the ACTOBAT follow-up study. McCormick MC Pediatrics; 1997 Mar; 99(3):476-8. PubMed ID: 9041308 [No Abstract] [Full Text] [Related]
80. Prenatal development of the pulmonary surfactant system and the influence of hypoxia. Orgeig S; Morrison JL; Daniels CB Respir Physiol Neurobiol; 2011 Aug; 178(1):129-45. PubMed ID: 21642020 [TBL] [Abstract][Full Text] [Related] [Previous] [Next] [New Search]